Google
APTOF — DMD DIGITAL HEALTH CONNECTIONS GROUP INC (Healthcare >> Biotechnology)
APTOF FAQ
What is APTOF's ROE?
DMD DIGITAL HEALTH CONNECTIONS GROUP INC reports a Return on Equity (ROE) of 93.75%.
What is APTOF's dividend yield?
DMD DIGITAL HEALTH CONNECTIONS GROUP INC offers a dividend yield of 0.00%.
What is APTOF's Deepscope Quality Score?
Deepscope rates APTOF's overall financial quality at 38 out of 100, based on profitability, growth, debt and earnings stability.
Is now a good time to buy APTOF?
Deepscope's AI Timing Score for APTOF is 0 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.
Which sector does APTOF belong to?
DMD DIGITAL HEALTH CONNECTIONS GROUP INC is classified under the Healthcare >> Biotechnology sector on the NASDAQ exchange.
|
USD 1.57
Price
-0.01
(-0.63%)
Day Change
|
|
|---|
APTOF, the overall quality is not good ( Quality = 38) and the timing to buy is ...(Sign In to See)...
Loading chart...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
ROA is relatively low.
Acceleration of ROE growth rate is below our criteria.
Negative growth of ROE in the last year.
ROE is decreasing significantly
ROA is too relatively low compare to ROE
Current growth of ROA was below our criteria.
Net profit margin is relatively low.
Acceleration of net profit margin growth rate is below our criteria
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Lorem ipsum dolor sit amet
In details, quality factors are not good , financial health is not good , and ability to make profit is not good , ...
| Quality Factors |
|
48% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 83 |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | 1.57 |
| PBV / Sector |
-0.15 / 4.63
|
| Earning Per Share | -9.98 |
| PE / Sector |
N/A / 17.43
|
| PEG or PE/Growth / Sector |
N/A / 0.53
|
| Average 1M Daily Value |
1355.725285000000
|
| Average 1W Daily Value |
791.105140000000
|
| Timing Factors |
|
14% |
| Financial Health |
|
37% |
| Ability to Make Profit |
|
37% |
| Return to Investors |
|
4% |
| Registration Details |
| Analyze Date | 2026-06-06 09:08:26 |
| Symbol | APTOF |
| Name | DMD DIGITAL HEALTH CONNECTIONS GROUP INC |
| Sector | Healthcare >> Biotechnology |
| Market | NASDAQ |
| Listed Shares | 2.55 M |
| Par Value | N/A |
| Calculated From | YearEnd |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 4.01 / 8,857.28 |
| News, Concensus, ... |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 66 Wellington Street West, Toronto, ON, Canada, M5K 1E6
Phone: 647 479 9828
Website: https://www.aptose.com
Sector: Healthcare >> Biotechnology
Description: Aptose Biosciences Inc., a clinical-stage biotechnology company, discovers and develops precision medicines addressing unmet medical needs in oncology primarily in the United States. The company's clinical-stage oral kinase inhibitors include tuspetinib (HM43239), a once-daily oral kinase inhibitor that has completed Phase 1/2 clinical trial targeting a select group of kinases operative in myeloid malignancies, such as acute myeloid leukemia and the higher risk myelodysplastic syndromes. It has license agreements with National Cancer Institute for the clinical development of tuspetinib; and Hanmi Pharmaceutical Co Ltd. to research, develop, and commercialize tuspetinib. The company was formerly known as Lorus Therapeutics Inc. and changed its name to Aptose Biosciences Inc. in August 2014. Aptose Biosciences Inc. was incorporated in 1986 and is headquartered in Toronto, Canada.
ME vs SECTOR Healthcare >> Biotechnology
Click a bubble to view stock details · Bubble size represents market capitalization share
